GILEAD SCIENCES, INC. Operating Leases, Rent Expense
GILEAD SCIENCES, INC. (GILD) reported Operating Leases, Rent Expense of $109.00 million for the 12-month period ending 2018-12-31, per its 10-K filed 2021-02-25.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2021-02-25
- GILEAD SCIENCES, INC. operating leases, rent expense for fiscal 2018 was $109.00M, a 29.76% increase from fiscal 2017.
- GILEAD SCIENCES, INC. operating leases, rent expense for fiscal 2017 was $84.00M, a 3.70% increase from fiscal 2016.
- GILEAD SCIENCES, INC. operating leases, rent expense for fiscal 2016 was $81.00M, a 3.85% increase from fiscal 2015.
- GILEAD SCIENCES, INC. operating leases, rent expense for fiscal 2015 was $78.00M, a 18.18% increase from fiscal 2014.
| Period end | Operating Leases, Rent Expense 12 month | Operating Leases, Rent Expense 12 month as first filed |
|---|---|---|
| 2018-12-31 | $109.00M 10-K · filed 2021-02-25 | |
| 2017-12-31 | $84.00M 10-K · filed 2020-02-25 | |
| 2016-12-31 | $81.00M 10-K · filed 2019-02-26 | |
| 2015-12-31 | $78.00M 10-K · filed 2018-02-27 | |
| 2014-12-31 | $66.00M 10-K · filed 2017-02-27 | |
| 2013-12-31 | $54.00M 10-K · filed 2016-02-24 | $53.60M 10-K · filed 2014-02-25 |
| 2012-12-31 | $54.00M 10-K · filed 2015-02-25 | $53.90M 10-K · filed 2013-02-27 |
| 2011-12-31 | $48.10M 10-K · filed 2014-02-25 | |
| 2010-12-31 | $41.70M 10-K · filed 2013-02-27 | |
| 2009-12-31 | $37.30M 10-K · filed 2012-02-23 | |
| 2008-12-31 | $29.30M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |